10-Hydroxy-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylic
acid tri-tert-butyl ester (2)
1699, 2948, 3494, 3540. UV/VIS (CH3CN): λmax (logε) = 206 nm
(4.297). H NMR (400 MHz, CDCl3): δ 2.86–4.14 (m, 16 H,
1
CH2), 5.22 (m, 2 H, CH2), 5.27 (m, 2 H, CH2), 7.35 (m, 10 H,
CH). 13C NMR (100 MHz, CDCl3): δ 47.93 (Ϫ), 48.70 (Ϫ),
48.92 (Ϫ), 49.76 (Ϫ), 60.48 (Ϫ), 61.24 (Ϫ), 61.39 (Ϫ), 67.67 (Ϫ),
67.74 (Ϫ), 127.78 (ϩ), 127.90 (ϩ), 127.94 (ϩ), 128.14 (ϩ),
128.34 (ϩ), 128.40 (ϩ), 128.65 (ϩ), 128.69 (ϩ), 128.71 (ϩ),
128.76 (ϩ), 156.37 (Cquart), 156.47 (Cquart), 175.26 (2 C, Cquart).
MS (ESI, MeOH/CH2Cl2 ϩ 1% AcOH): m/z (%) = 473 (100)
1,4,7-Tris-tert-butoxycarbonyl-1,4,7,10-tetraazacyclododecane
1 (0.50 g, 1.06 mmol) was dissolved in 5 mL of degassed
acetone. Under cooling in an ice-bath 16 mL of dimethyl-
dioxirane in acetone (ca. 0.1 M) were added slowly. The reaction
mixture was then stirred for 4 h at room temperature. The
solvent was evaporated and the crude product was purified by
column chromatography on silica (eluent: ethyl acetate, Rf =
0.6). The hydroxylamine 2 (0.42 g, 0.86 mmol, 81%) was
ϩ
[MHϩ], 495 (2) [MNaϩ]; HRMS (C24H33N4O6 ): calc. 473.2400,
found. 473.2391 0.0006. Anal. calc. for C24H32N4O6ؒ2H2O: C,
56.68; H, 7.13; N, 11.02. Found: C, 56.83; H, 7.13; N, 11.02%.
—
obtained as a white solid. M.p. 84 ЊC. IR (KBr, cmϪ1): ν = 775,
1174, 1249, 1366, 1420, 1466, 1694, 2933, 2977, 3428. 1H NMR
(250 MHz, CDCl3): δ 1.45 (s, 18 H, CH3), 1.47 (s, 9 H, CH3),
2.91 (bs, 4 H, CH2), 3.31–3.95 (m, 12 H, CH2), 5.85 (bs, 1 H,
OH). 13C NMR (62 MHz, CDCl3): δ 28.47 (ϩ), 28.69 (ϩ), 45.27
(Ϫ), 46.14 (Ϫ), 47.81 (Ϫ), 48.15 (Ϫ), 49.57 (Ϫ), 50.14 (Ϫ), 59.07
(Ϫ), 59.69 (Ϫ), 79.41 (Cquart), 79.81 (Cquart), 79.94 (Cquart),
155.36 (Cquart), 156.07 (Cquart), 156.41 (Cquart). MS (ESI, MeOH/
CH2Cl2ϩ 1% AcOH): m/z (%) = 489 (100) [MHϩ]. Anal. calc.
for C23H44N4O7: C, 56.54; H, 9.08; N, 11.47. Found: C, 56.40;
H, 9.33; N, 11.12%.
1,4,7,10-Tetraazacyclododecane-1,7-diol di-hydrobromide
Compound 5 (0.28 g, 0.60 mmol) was mixed with 3.0 mL of
HBr in glacial acetic acid (33%, 4.1 M) and stirred for 30 min at
room temperature. Then 5 mL of diethyl ether were added to
the suspension. The precipitate was collected by suction
filtration and washed with diethyl ether. The hydrobromide
(0.20 g, 0.55 mmol, 93%) was obtained as a colourless powder.
—
M.p. 151 ЊC. IR (KBr, cmϪ1): ν = 1457, 1705, 2762, 2960, 3046,
1
3259, 3427. H NMR (250 MHz, D2O): δ 3.04–3.48 (m, CH2).
1,4,7,10-Tetraazacyclododecan-1-ol tri-hydrobromide
13C NMR (62 MHz, D2O): δ 42.91 (Ϫ), 45.02 (Ϫ), 53.08 (Ϫ).
MS (ESI, H2O): m/z (%) = 205 (100) [MHϩ]. Anal. calc. for
C8H22Br2N4O2ؒ0.5CH3CH2OCH2CH3: C, 29.79; H, 6.75; N,
13.90. Found: C, 30.23; H, 6.22; N, 14.18%.
Compound 2 (0.30 g, 0.62 mmol) was mixed with 2.0 mL of
HBr in glacial acetic acid (33%, 4.1 M) and stirred for 30 min at
room temperature. Then 5 mL of diethyl ether were added to
the suspension. The precipitate was collected by suction
filtration and washed with diethyl ether. The hydrobromide
(0.24 g, 0.56 mmol, 91%) was obtained as a colourless powder.
1,4,7,10-Tetraazacyclododecane-1,7-diol-zinc(II) di-perchlorate
(6)
—
Decomp. at 210 ЊC. IR (KBr, cmϪ1): ν = 1635, 2760, 2926, 3422.
Compound 6 was synthesized from the above hydrobromide
(0.20 g, 0.55 mmol) by a method similar to that of 3. The com-
plex 6 (0.15 g, 0.33 mmol, 60%) was obtained as a white solid.
1H NMR (250 MHz, D2O): δ 2.84–3.52 (m, CH2). 13C NMR
(100 MHz, D2O): δ 42.61 (Ϫ), 43.39 (Ϫ), 44.04 (Ϫ), 54.39 (Ϫ).
MS (ESI, H2O): m/z (%) = 189 (100) [MHϩ]. Anal. calc. for
C8H23Br3N4Oؒ0.5CH3COOH: C, 23.45; H, 5.47; N, 12.15.
Found: C, 23.03; H, 5.46; N, 12.53%.
—
M.p. 138–140 ЊC. IR (KBr, cmϪ1): ν = 628, 1090, 1389, 1450,
2941, 3167, 3224, 3422. 1H NMR (250 MHz, CD3CN): δ
2.65–2.75 (m, 4 H, CH2), 3.02–3.27 (m, 12 H, CH2), 3.71 (bs, 2
H, NH), 7.12 (bs, 1 H, OH), 7.39 (bs, 1 H, OH). 13C NMR
(62 MHz, CD3CN): δ 44.05 (Ϫ), 56.65 (Ϫ). MS (ESI, MeOH ϩ
10 mmol NH4Ac): m/z (%) = 327 (100) [(62ϩ ϩ CH3COOϪ)ϩ].
1,4,7,10-Tetraazacyclododecan-1-ol-zinc(II) di-perchlorate (3)
The above hydrobromide (0.22 g, 0.51 mmol) was dissolved in
2 mL of H2O and eluted over a basic anion exchange column.
The solution was evaporated to dryness and the solid residue
was dissolved in 2 mL of methanol. Then a solution of
Zn(ClO4)2ؒ6H2O (0.28 g, 0.75 mmol) in 2 mL of methanol was
added and the mixture was heated at 80 ЊC for 45 min. After
removal of most of the solvent, the reaction mixture was cooled
in an ice-bath and the precipitate was collected by suction
filtration. Complex 3 (0.15 g, 0.33 mmol, 65%) was isolated as a
Potentiometric titrations
Potentiometric pH titrations were performed with a computer-
controlled pH-meter (pH 3000, WTW; glass pH electrode
Metrohm) and automatic titration apparatus (dosimat 665,
Metrohm). For all titrations 0.1 M perchloric acid (Merck, p.a.)
and 0.1 M tetraethylammonium hydroxide (TEAOH) (Merck,
p.a.) in water containing tetraethylammonium perchlorate to
maintain an ionic strength of I = 0.1 mol LϪ1 were used. The
water used is of ultrapure HPLC grade deionized with the
Milli-Q185 apparatus form Millipore. Tetraethylammonium
perchlorate (Fluka, purum) was recrystallized twice from
acetonitrile. TEAOH solutions were calibrated with mono
sodium phthalate (Merck, p.a.). A titration of perchloric acid
with TEAOH solution was used for calibration and to deter-
mine log Kw and AI by the method of Gran.19 Titrations were
measured over a pH range from 2.7 to 12.6 with a minimum of
80 data points recorded. Titrations were performed in duplicate
or triplicate. The stability constants given and their standard
deviations are average values. All measurements were performed
—
white solid. Decomp. at 235 ЊC. IR (KBr, cmϪ1): ν = 628, 1089,
1459, 2933, 3163, 3254, 3410. 1H NMR (250 MHz, CD3CN): δ
2.60–2.79 (m, 4 H, CH2), 2.84–3.20 (m, 12 H, CH2), 3.36 (bs, 3
H, NH), 6.73 (bs, 1 H, OH). 13C NMR (62 MHz, CD3CN): δ
43.77 (Ϫ), 44.97 (Ϫ), 45.15 (Ϫ), 56.23 (Ϫ). MS (ESI, H2O ϩ 1%
AcOH): m/z (%) = 311 (100) [(32ϩ ϩ CH3COOϪ)ϩ], 351 (35)
[(32ϩ ϩ ClO4 )ϩ]. Anal. calc. for C8H20Cl2N4O9Znؒ0.5CD3CN:
Ϫ
C, 22.78; H, 4.88; N, 13.28. Found: C, 22.92; H, 4.98; N,
13.18%.
4,10-Dihydroxy-1,4,7,10-tetraazacyclododecane-1,7-dicarb-
oxylic acid dibenzyl ester (5)
at 25
0.5 ЊC. Data and error analysis was done with the
1,7-Bis(benzyloxycarbonyl)-1,4,7,10-tetraazacyclododecane
4
computer program Hyperquad 2000.20
(0.70 g, 1.60 mmol) was dissolved in 10 mL of degassed acet-
one. Under cooling in an ice-bath 41 mL of dimethyldioxirane
in acetone (ca. 0.1 M) were added. The reaction mixture was
then stirred for 30 min in the ice-bath and for a further 40 min
at room temperature. The solvent was evaporated and the crude
product was purified by column chromatography on silica
(eluent: CH2Cl2–MeOH = 10:1, Rf = 0.8). The hydroxylamine 5
(0.34 g, 0.73 mmol, 46%) was isolated as a white solid. M.p. 54
Crystal structure determination
Suitable crystals for X-ray experiments of complex 3 were
obtained by slow evaporation of a methanolic solution.
Formula: C8H20BrN4OZnؒClO4, M = 433.02, crystal system:
orthorhombic, space group P212121, a = 8.9049(5), b =
12.2325(8), c = 14.0969(11) Å, α = β = γ = 90Њ, V = 1535.56(18)
Å3, Z = 4, Dc = 1.873 g cmϪ3, F(000) = 872, µ = 4.398 mmϪ1,
—
ЊC. IR (KBr, cmϪ1): ν = 772, 1020, 1167, 1260, 1361, 1412, 1479,
D a l t o n T r a n s . , 2 0 0 3 , 1 4 1 – 1 4 5
144